Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- Check4 days agoChange DetectedNew entry on 2026-01-20 adds a Study Status update. The 2025-01-17 record is removed, updating the version history.SummaryDifference0.3%

- Check11 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page history. This reflects a minor software update to the site.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedFooter revision notice updated to Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedThe new version removes the government funding operating-status notice that previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange DetectedThe old and new screenshots display the same list of study record versions with no additional status changes or essential data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.